RAG-induced DNA double-strand breaks signal through Pim2 to promote pre-B cell survival and limit proliferation by Bednarski, Jeffrey J et al.




RAG-induced DNA double-strand breaks signal
through Pim2 to promote pre-B cell survival and
limit proliferation
Jeffrey J. Bednarski
Washington University School of Medicine in St. Louis
Andrew Nickless
Washington University School of Medicine in St. Louis
Deepta Bhattacharya
Washington University School of Medicine in St. Louis
Rupesh H. Amin
Fred Hutchinson Cancer Research Center
Mark S. Schlissel
University of California - Berkeley
See next page for additional authors
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
Part of the Medicine and Health Sciences Commons
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Bednarski, Jeffrey J.; Nickless, Andrew; Bhattacharya, Deepta; Amin, Rupesh H.; Schlissel, Mark S.; and Sleckman, Barry P., ,"RAG-
induced DNA double-strand breaks signal through Pim2 to promote pre-B cell survival and limit proliferation." Journal of
Experimental Medicine.209,1. 11-17. (2012).
http://digitalcommons.wustl.edu/open_access_pubs/823
Authors
Jeffrey J. Bednarski, Andrew Nickless, Deepta Bhattacharya, Rupesh H. Amin, Mark S. Schlissel, and Barry P.
Sleckman
This open access publication is available at Digital Commons@Becker: http://digitalcommons.wustl.edu/open_access_pubs/823
The Rockefeller University Press $30.00
J. Exp. Med. Vol. 209 No. 1 11-17
www.jem.org/cgi/doi/10.1084/jem.20112078
11
Brief Definit ive Report
B cell development relies on coordinate signals 
from cell surface antigen and cytokine recep-
tors. IgH chain antigen receptor genes are 
assembled in pro–B cells and pair with the 
surrogate light chain (5 and VpreB) to form 
the pre–B cell receptor (BCR) (Herzog et al., 
2009). Signals from the pre-BCR drive cellular 
expansion, transit from the pro–B to pre–B cell 
stage, and initiation of IgL chain gene assembly 
(Herzog et al., 2009). At the pre–B cell stage, 
successful assembly of an IgL chain gene and 
subsequent pairing with the IgH chain leads to 
the expression of a BCR, which signals termi-
nation of antigen receptor gene assembly and 
promotes transition to the immature B cell stage 
(Bassing et al., 2002; Herzog et al., 2009).
Antigen receptor genes are assembled through 
V(D)J recombination, a reaction initiated by the 
RAG1 and RAG2 proteins, which together form 
the RAG endonuclease (Fugmann et al., 2000). 
V(D)J recombination is restricted in developing 
lymphocytes to the G1 phase of the cell cycle, in 
part as a result of the degradation of RAG2 in 
S phase (Desiderio et al., 1996). RAG introduces 
DNA double-strand breaks (DSBs) at the border 
of two recombining gene segments (V, D, or J) 
and their flanking RAG recognition sequences, 
termed recombination signals (Fugmann et al., 
2000). RAG DNA cleavage forms two blunt sig-
nal ends and two hairpin-sealed coding ends. 
These DNA ends are processed and joined by 
the nonhomologous end-joining (NHEJ) path-
way of DNA repair to form a signal joint and a 
coding joint, which completes formation of the 
second exon of antigen receptor genes (Rooney 
et al., 2004). The DNA breaks generated during 
this process activate the ATM kinase, which pro-
motes canonical DNA damage responses, includ-
ing cell death pathways which ultimately kill cells 
with persistent unrepaired RAG DSBs (Gapud 
and Sleckman, 2011).
In addition to pre-BCR and BCR signals, 
IL-7 receptor signals are important to promote 
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Interleukin 7 (IL-7) promotes pre–B cell survival and proliferation by activating the Pim1 and 
Akt kinases. These signals must be attenuated to induce G1 cell cycle arrest and expression of 
the RAG endonuclease, which are both required for IgL chain gene rearrangement. As lost  
IL-7 signals would limit pre–B cell survival, how cells survive during IgL chain gene rearrange-
ment remains unclear. We show that RAG-induced DNA double-strand breaks (DSBs) gener-
ated during IgL chain gene assembly paradoxically promote pre–B cell survival. This occurs 
through the ATM-dependent induction of Pim2 kinase expression. Similar to Pim1, Pim2 
phosphorylates BAD, which antagonizes the pro-apoptotic function of BAX. However, unlike 
IL-7 induction of Pim1, RAG DSB-mediated induction of Pim2 does not drive proliferation. 
Rather, Pim2 has antiproliferative functions that prevent the transit of pre–B cells harboring 
RAG DSBs from G1 into S phase, where these DNA breaks could be aberrantly repaired. Thus, 
signals from IL-7 and RAG DSBs activate distinct Pim kinase family members that have 
context-dependent activities in regulating pre–B cell proliferation and survival.
© 2012 Bednarski et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
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induction of Pim1, Pim2 has distinct context-dependent sur-
vival and proliferative activities in cells undergoing V(D)J 
recombination. Our findings establish that signals from RAG 
DSBs are coordinated with those from the IL-7 receptor to reg-
ulate the survival and proliferation of developing pre–B cells.
RESULTS AND DISCUSSION
Pim1 and Akt provide survival signals in response to IL-7
Large proliferating pre–B cells require the continuous presence of 
IL-7 (Fig. 1 A; Milne and Paige, 2006). IL-7 induces expression 
of the Pim1 kinase, which promotes survival as indicated by the 
enhanced uptake of 7AAD in Pim1/ pre–B cells compared 
with wild-type (Pim1+/+) pre–B cells in the presence of IL-7 
survival and proliferation of developing B cells (Milne and Paige, 
2006). The IL-7 receptor activates the JAK–STAT (STAT5) 
pathway, which induces the expression of Pim1 (Goetz et al., 
2004). Pim1 is a member of a family of constitutively active 
serine-threonine kinases, which also includes Pim2 and Pim3, and 
supports lymphocyte proliferation and survival (Amaravadi and 
Thompson, 2005; Nawijn et al., 2011). The importance of IL-7 
receptor signals is indicated by the block in B cell development 
observed in mice deficient for IL-7, IL-7 receptor, or STAT5 
(Malin et al., 2010b; Milne and Paige, 2006). Pim1-deficient 
mice exhibit defects in B cell development, albeit to a lesser 
extent than mice compromised for IL-7 signaling (Domen 
et al., 1993). The incomplete developmental block in Pim1/ 
mice suggests that other signaling pathways can contribute to 
pre–B cell proliferation and survival. In this regard, in develop-
ing T cells, IL-7 activates both Pim1 and the Akt kinase to 
support cell survival (Li et al., 2004). Whether Akt has a similar 
prosurvival function in developing B cells is not known.
Although IL-7 signals are critical for developing pre–B cells, 
these signals must be attenuated during IgL chain gene 
assembly as: (1) IL-7 signals suppress RAG gene expression in 
pre–B cells, (2) proliferative signals from IL-7 promote the 
degradation of RAG2 as cells pass into S phase, (3) persistent 
proliferative signals promote genomic instability by transiting 
cells with RAG DSBs into S phase before these DNA breaks can 
be repaired by NHEJ, and (4) IL-7 signals negatively regulate IgL 
gene accessibility (Billips et al., 1995; Desiderio et al., 1996; Amin 
and Schlissel, 2008; Johnson et al., 2008; Malin et al., 2010a). 
Recent studies have suggested that IL-7 signaling in pre–B cells 
may be attenuated through the pre-BCR–mediated expression 
of CXCR4, which may promote migration of pre–B cells 
away from IL-7–producing stromal cells in the bone marrow 
(Tokoyoda et al., 2004; Johnson et al., 2008).
Despite the importance of attenuating IL-7 proliferative sig-
nals, lost IL-7 survival signals could limit the time for pre–B cells 
to assemble a functional IgL chain gene. IgL gene assembly 
occurs through the rearrangement of a V gene segment to 
one of four J gene segments. The structure of the locus is such 
that multiple V to J rearrangements can, and often do, occur 
on a single allele. A single rearrangement can take several hours 
to complete and, thus, pre–B cells may have to survive for an 
extended period of time as they iteratively assemble IgL genes 
in an attempt to express a functional IgL chain (Casellas et al., 
2001). Moreover, cells that fail to generate an IgL chain gene 
often go on to attempt IgL chain gene assembly (Arakawa 
et al., 1996). What promotes the survival of pre–B cells that are 
assembling IgL chain genes is largely unknown.
In response to RAG DSBs, the activation of ATM induces 
a broadly functional genetic program (Bredemeyer et al., 2008). 
In this paper, we develop an experimental approach designed to 
elucidate the function of signaling pathways activated by RAG 
DSBs in the regulation of B cell development. We find that 
RAG DNA breaks generated during IgL chain gene rearrange-
ment promote the survival of pre–B cells that have lost IL-7 sig-
nals. This cytokine-independent survival requires the induction 
of Pim2 expression by RAG DSBs. When compared with IL-7 
Figure 1. Akt and Pim1 promote IL-7-dependent survival. (A) Cell 
death assessed by 7AAD uptake in wild-type pre–B cells cultured in IL-7 
(+IL-7) and 48 h after IL-7 withdrawal (IL-7). (B) Western blot analysis of 
Pim1, phosphorylated Foxo1 (p-Foxo1), phosphorylated Akt (p-Akt), and 
total Akt in whole cell lysates from wild-type pre–B cells in IL-7 (+) and 48 h 
after IL-7 withdrawal (). Gapdh is shown as a protein loading control. 
Numbers represent band intensity relative to +IL-7 and standardized to 
loading controls. (C) Cell death assessed by 7AAD uptake in wild-type 
(Pim1+/+) and Pim1/ pre–B cells cultured for 48 h in media containing 
IL-7 and 5 µM Akt inhibitor VIII (+) or DMSO () for 48 h. Shown is the 
mean and standard deviation from three independent experiments. Data in 
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further development is blocked as a result of the inability to 
generate a functional IgL chain gene (Fig. S1; Bassing et al., 
2002; Herzog et al., 2009).
Southern blot analysis of genomic DNA from Artemis/:
IgH:Bcl2 pre–B cells cultured in IL-7 reveals low levels of 
unrepaired J coding ends generated by RAG cleavage be-
cause IL-7 suppresses, but does not abrogate, V(D)J recombi-
nation (Fig. 2 A; Milne et al., 2004). IL-7 withdrawal enhances 
RAG expression, leading to increased generation of J coding 
ends in Artemis/:IgH:Bcl2 pre–B cells (Fig. 2 A). These 
DNA DSBs lead to the phosphorylation of p53 (Fig. 2, B 
and C). p53 phosphorylation was not observed in RAG1/:
IgH:Bcl2 pre–B cells or in Artemis/:IgH:Bcl2 pre–B cells 
treated with the ATM inhibitor KU55933 (Fig. 2, B and C). 
Thus, RAG DSBs activate ATM and downstream DNA 
damage responses in pre–B cells.
Pre–B cells with RAG DSBs exhibit enhanced survival
Phosphorylation of the proapoptotic transcription factor p53 
in response to RAG DSBs should promote cell death in 
Artemis-deficient compared with Rag-deficient pre–B cells. 
To determine the effect of RAG DSBs on pre–B cell sur-
vival, we generated RAG- and Artemis-deficient mice that 
did not contain the Bcl2 transgene (Rag1/:IgH and Arte-
mis/:IgH mice, respectively). Surprisingly, Artemis/:IgH 
pre–B cells exhibited increased viability compared with 
RAG1/:IgH pre–B cells at early time points (24 h) after 
withdrawal of IL-7 (Fig. 2 D). Moreover, Artemis/:IgH 
pre–B cells have increased survival in IL-7 (0 h), where RAG 
DSBs are also generated and p53 is phosphorylated (Fig. 2). 
(Fig. 1, B and C; Domen et al., 1993). However, survival is not 
completely abrogated in Pim1/ pre–B cells, suggesting that 
IL-7 regulates additional prosurvival pathways. In this regard, the 
Akt kinase is activated in pre–B cells by IL-7 as indicated by its 
autophosphorylation and the phosphorylation of Foxo-1, a 
known target of Akt in pre–B cells (Fig. 1 B; Amin and Schlissel, 
2008). Inhibition of Akt kinase activity with Akt inhibitor VIII 
leads to an increase in pre–B cell death in the presence of IL-7 
(Fig. 1 C). Additionally, treatment of Pim1/ pre–B cells with 
this inhibitor leads to a synergistic increase in cell death (Fig. 1 C). 
Together, these findings demonstrate that Pim1 and Akt function 
to regulate pre–B cell survival in response to IL-7.
RAG DSBs activate DNA damage responses in pre–B cells
To elucidate the signaling pathways downstream of RAG 
DSBs in pre–B cells, we generated mice that carry IgH and 
Bcl2 transgenes and are deficient in RAG1 or the NHEJ 
factor Artemis (RAG1/:IgH:Bcl2 and Artemis/:IgH:Bcl2 
mice, respectively; Fig. S1). Artemis is a nuclease that is 
required to open hairpin sealed coding ends (Rooney et al., 
2004). Thus, cells deficient in Artemis cannot make coding 
joints and mice deficient in Artemis have a block in B cell 
development at the pro–B cell stage as a result of their inabil-
ity to generate a functional IgH chain gene (Rooney et al., 
2004). Mice deficient in RAG1 cannot generate RAG DSBs 
and thus also exhibit a block at the pro–B cell stage (Fugmann 
et al., 2000). However, the inclusion of an IgH transgene 
in RAG1/:IgH:Bcl2 and Artemis/:IgH:Bcl2 mice allows 
for pre-BCR expression and transit from the pro–B cell 
(B220+CD43+) to the pre–B cell stage (B220+CD43) where 
Figure 2. RAG DSBs support pre–B cell 
survival. (A) A schematic of the germline (GL) 
IgL locus and unrepaired J1 and J2 coding 
ends (CEs) are shown. V and J gene segments 
(rectangles) and their associated recombination 
sequences (triangles) are shown as are the rela-
tive positions of the EcoRI and SacI sites and the 
JIII probe used for Southern blot analyses. 
Southern blot analysis of genomic DNA from 
RAG1/:IgH:Bcl2, and Artemis/:IgH:Bcl2  
pre–B cells cultured in IL-7 (0 h) and after IL-7 
withdrawal (wd, 48 h). Hybridizing bands  
generated by the GL IgL locus and J1 and J2  
un-repaired CEs are indicated. (B) Western blot 
analysis of phosphorylated p53 (p-p53) after 
withdrawal of IL-7 for the indicated times. 
Gapdh is shown as a protein loading control. 
Numbers represent band intensity relative to 
Artemis/:IgH:Bcl2 at time 0 h and standard-
ized to loading controls. No quantitation is pre-
sented for RAG1/:IgH:Bcl2 as no bands are 
present. (C) Western blot analysis of p-p53 after 
IL-7 withdrawal in Artemis/:IgH:Bcl2 treated 
with vehicle (DMSO) or the ATM inhibitor 
KU55933. Gapdh is shown as protein loading control. Numbers represent band intensity relative to time 0 h and standardized to loading controls. (D) Viability 
assessed by 7AAD uptake after withdrawal of IL-7 for the indicated times. Shown is the mean and standard deviation for three replicates. **, P < 0.0001; *, P = 
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Figure 3. Pim2 induction by RAG DSBs promotes pre–B cell survival. (A) Western blot analysis of p-Akt and Pim1 in Artemis/:IgH:Bcl2 pre–B cells 
after withdrawal of IL-7 for indicated times. Gapdh is shown as a protein loading control. Numbers represent band intensity relative to time 0 h and  
standardized to loading controls. (B and C) Western blot analysis of Pim2 expression at indicated times after IL-7 withdrawal. Arrows indicate the three 
Pim2 isoforms and the asterisk indicates a nonspecific band. Gapdh is shown as a protein loading control. Numbers represent band intensity relative to 
RAG1/:IgH:Bcl2 (B) or Artemis/:IgH:Bcl2 (C) at time 0 h and standardized to loading controls. (D) Cell death assessed by 7AAD uptake 24 h after with-
drawal of IL-7 from Artemis/:IgH and Artemis/:Pim2/:IgH pre–B cells. Shown is the mean and standard deviation for three replicates. (E) Arte-
mis/:IgH pre–B cells were transduced with retroviral vector (red peaks) expressing hCD2 and shEGFP (control) or hCD2 and shPim2 then subsequently 
withdrawn from IL-7 as mixed co-cultures with nontransduced cells (white peaks). Histograms demonstrate percentage of transduced cells (hCD2+, red 
peak) before (+IL-7) and 72 h after (IL-7) withdrawal of IL-7. The experiment was conducted in duplicate with P = 0.008 for shPim2 compared with 
shEGFP at 72 h. (F) RAG1/:IgH pre–B cells were transduced with empty retroviral vector (empty), retrovirus-expressing Pim2 (Pim2), or retrovirus- 
expressing kinase-dead version of Pim2 (Pim2-KD). IL-7 was withdrawn from mixed cultures of transduced and nontransduced cells. Retrovirally transduced  
cells were followed by Thy1.1 expression. Data represents the fold increase in the percentage of retrovirally transduced cells at 72 h after IL-7 withdrawal 
relative to the percentage in the presence of IL-7. Shown is the mean and standard deviation for duplicate cultures. (G) BAX mRNA expression assessed by 
RT-PCR in cells cultured in IL-7 (+) and 48 h after () IL-7 withdrawal. Shown is the mean and standard deviation for three replicates. (H) BAX mRNA 
expression assessed by RT-PCR at indicated times after IL-7 withdrawal. Shown is the mean and standard deviation for three replicates. (I) PUMA and 
NOXA mRNA expression assessed by RT-PCR in cells cultured in IL-7 (+) and 72 h after () IL-7 withdrawal. Shown is the mean and standard deviation 
for three replicates. (J) Western blot analysis of p-p53 after withdrawal from IL-7 for the indicated times. Gapdh is shown as a protein loading control. 
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Bad (p-Bad) 96 h after IL-7 withdrawal. Gapdh is shown as a protein loading control. Numbers represent band intensity relative to RAG1/:IgH:Bcl2 and 
standardized to loading controls. All data are representative of at least three experiments.
 
These data demonstrate that RAG DSBs activate prosurvival 
pathways that may antagonize the proapoptotic effects of 
p53 in pre–B cells.
Pim2 promotes survival downstream of RAG DSBs
Upon withdrawal of IL-7, pre–B cells lose Pim1 and Akt sur-
vival signals leading to cell death (Fig. 1). However, early after 
the initiation of V(D)J recombination, pre–B cells exhibit en-
hanced survival suggesting that RAG DNA breaks may gener-
ate compensatory survival signals (Fig. 2 D). In contrast to IL-7 
signals, RAG DSBs do not activate Akt or induce Pim1 expres-
sion (Fig. 3 A). Rather, these DNA breaks induce Pim2 kinase 
expression as indicated by Western blot analysis of Artemis/:
IgH:Bcl2 and RAG1/:IgH:Bcl2 pre–B cells in the presence or 
absence of IL-7 (Fig. 3 B). RAG DSBs in pre–B cells with a 
compound deficiency in Artemis and ATM (Artemis/:
ATM/:IgH:Bcl2) do not induce Pim2 expression (Fig. 3 C). 
Thus, whereas Pim1 and Akt activities are down-regulated 
upon IL-7 withdrawal, Pim2 expression is induced after ATM 
activation by RAG DSBs during IgL chain gene assembly.
To determine whether Pim2 promotes pre–B cell survival, 
we analyzed the response to RAG DSBs in pre–B cells deficient 
in both Artemis and Pim2 (Artemis/:Pim2/:IgH). After 
withdrawal of IL-7, Artemis/:Pim2/:IgH pre–B cells exhibit 
increased cell death compared with Artemis/:IgH pre–B cells 
(Fig. 3 D). Similarly, knockdown of Pim2 in Artemis/:IgH 
pre–B cells leads to decreased viability, as indi-
cated by a more significant loss of Artemis/:
IgH pre–B cells expressing a Pim2 short hairpin RNA (shRNA) 
compared with those expressing a control shRNA after IL-7 
withdrawal (Fig. 3 E, human CD2-expressing cells). Further-
more, RAG1/:IgH pre–B cells transduced with a retrovirus 
expressing Pim2 exhibit enhanced survival after withdrawal of 
IL-7 compared with cells expressing the empty vector (Fig. 3 F). 
Expression of a kinase-deficient mutant of Pim2 (Pim2-KD) in 
RAG1/:IgH pre–B cells had no effect on survival after with-
drawal of IL-7 (Fig. 3 F; Fox et al., 2003). Together, these find-
ings demonstrate that RAG DSBs promote the expression of 
Pim2 and that Pim2 kinase activity augments the survival of 
pre–B cells undergoing IgL chain gene assembly. Consistent 
with this notion, Pim2/ mice have reduced numbers of IgL-
expressing B cells (Derudder et al., 2009).
Pim2 phosphorylates Bad in response to RAG DSBs
In pre–B cells, p53 is phosphorylated by ATM in response to 
RAG DSBs (Fig. 2, B and C). Upon IL-7 withdrawal, expres-
sion of the proapoptotic BAX gene, a target of p53, is up- 
regulated by ATM in response to RAG DSBs (Fig. 3, G and H; 
Vousden and Prives, 2009). The proapoptotic genes NOXA 
and PUMA, which function by promoting BAX activity, also 
exhibited increased expression upon IL-7 withdrawal (Fig. 3 I; 
Youle and Strasser, 2008). However, this increase was similar 
in Artemis/:IgH pre–B cells and RAG1/:IgH pre–B cells, 
demonstrating that it is not caused by RAG DSBs (Fig. 3 I). 
Figure 4. Pim2 attenuates IL-7-driven proliferation 
in cells with RAG DSBs. (A) RAG1/:IgH:Bcl2, Arte-
mis/:IgH:Bcl2, and Artemis/:Pim2/:IgH:Bcl2 were 
cultured in IL-7 and the percent of cells in S phase was 
assessed by BrdU incorporation. Shown is the mean and 
standard deviation for two replicates. (B–C) Artemis/:
Pim2/:IgH:Bcl2 (B) and RAG1/:IgH:Bcl2 (C) pre–B cells 
were transduced with an empty retroviral vector (empty) 
or retrovirus expressing Pim2 (Pim2). Cells were cultured 
in IL-7 and the percent of S-phase cells was assessed by 
BrdU incorporation 3 d after retroviral transduction. 
Shown is the mean and standard deviation of two repli-
cates. Data in A, B, and C are representative of at least 
three experiments. (D) Model illustrating context-depen-
dent roles of Pim1 and Pim2 in developing pre–B cells. 
Red lines represent inhibition and black arrows designate 
activation. Pim1 and Akt activity are triggered by IL-7 
receptor signals. These two kinases cooperate to support 
pre–B cell survival through phosphorylation of BAD and 
subsequent inactivation of BAX. Expression of Pim1 also 
supports IL-7–driven proliferation. Loss of IL-7 leads to 
loss of Pim1 and Akt activities, expression of RAG, and 
initiation of IgL chain gene rearrangement. RAG DSBs 
activate ATM, which induces Pim2 expression. Pim2 phos-
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pre–B cells (Fig. 4 D). To assemble IgL chain genes, pre–B cells 
must attenuate IL-7 signals, including those that promote sur-
vival. Importantly, we show that RAG DSB-mediated signals 
support pre–B cell survival, effectively replacing lost IL-7 pro-
survival signals. However, if these DSBs persist unrepaired, they 
would ultimately promote cell death. This temporal balance of 
prosurvival and proapoptotic signaling would allow pre–B cells 
the time needed to undergo multiple IgL chain gene rearrange-
ments while, ultimately, eliminating any cells with persistent 
unrepaired RAG DSBs. These activities, coupled with the cell 
cycle checkpoint activity of Pim2, permit efficient IgL chain 
gene assembly and prevent RAG DSBs from being aberrantly 
resolved as chromosomal lesions, such as translocations, which 
could lead to cellular transformation and cancer.
MATERIALS AND METHODS
Mice. All mice were bred and maintained under specific pathogen-free condi-
tions at the Washington University School of Medicine and were handled in 
accordance with the guidelines set forth by the Division of Comparative Med-
icine of Washington University. Wild-type B6 mice (The Jackson Laboratory) 
were used as controls. All other mice are on a mixed genetic background.
Primary cell culture. Bone marrow was harvested from 4–6-wk-old mice 
and cultured for 7–10 d at 2 × 106 cells/ml in media containing IL-7 at 5 ng/ml. 
For IL-7 withdrawal experiments, cells were resuspended in media without IL-7 
and maintained at 2 × 106 cells/ml. The ATM inhibitor KU-55933 (Sigma-
Aldrich) was used at 15 µM. Akt inhibitor VIII (EMD) was used at 5 µM.
cDNA expression and shRNA mediated knockdown. cDNAs encod-
ing Pim2 or Pim2-KD were cloned into the MSCV retrovirus containing an 
IRES sequence followed by Thy1.1 cDNA as a marker of transduced cells. 
For Pim2-KD, the lysine at residue 121 was changed to methionine by 
PCR-based site-directed mutagenesis of Pim2 cDNA and confirmed by se-
quencing (Fox et al., 2003). shRNAs were cloned into the MSCV-hCD2-
mir30 vector as previously described (Amin and Schlissel, 2008). Targeted 
sequences are as follows: Pim2, 5-GGGAGGTACTGCTCATTAA-3; 
and p53, 5-CCCACTACAAGTACATGTGTAA-3. Retrovirus was pro-
duced in platE cells by transfection of the retroviral plasmid with Lipo-
fectamine 2000 (Invitrogen) according to the manufacturer’s protocol. Viral 
supernatant was collected and pooled from 24–72 h after transfection. Viral 
particles were concentrated by addition of PEG-8000 (Sigma-Aldrich; final 
concentration 8%), incubation at 4°C overnight, and centrifugation at 2,500 
RPM for 20 min. Precipitated virus was resuspended at 300× concentration 
in sterile PBS. Cells (10 × 106/ml) were transduced with viral particles (final 
6-10×) in standard media containing 5 µg/ml polybrene and centrifuged for 
2 h at 1,100 RPM at room temperature. Cells were incubated overnight in 
virus-containing media and then placed in fresh media at 2 × 106 cells/ml. 
Cells expressing the retroviral construct were identified by flow cytometric 
assessment of Thy1.1 or hCD2 expression using a FACSCalibur (BD). 
Transduced cells were sorted using biotin-hCD2 or biotin-Thy1.1 (both 
from BD) and anti-biotin magnetic beads (Miltenyi Biotec) on MS columns 
(Miltenyi Biotec) according to the manufacturer’s protocol.
Flow cytometric analyses. All flow cytometric analyses were performed 
on a FACSCalibur. Antibodies used included FITC-conjugated anti-CD45R/
B220 and allophycocyanin (APC)-conjugated anti-IgM, PE-conjugated 
anti-CD43, APC-conjugated anti-hCD2, PE-conjugated anti-hCD2, and 
PE-conjugated anti-Thy1.1. All antibodies were obtained from BD. Cell vi-
ability was assessed by incubation of cells for 10 min at room temperature 
with 0.5 µg/ml of 7AAD (BD). Proliferation was assessed using the BrdU-
FITC kit (BD) per the manufacturer’s instructions.
Southern blot. Southern blot analyses of coding ends generated during 
rearrangement at the IgL locus were performed on genomic DNA 
Notably, the expression of BAX, NOXA, and PUMA is not 
altered by Pim2 deficiency (Fig. 3, H and I). Moreover, Pim2 
does not modulate p53 phosphorylation (Fig. 3 J).
How then does Pim2 inhibit pre–B cell apoptosis? Like 
PUMA and NOXA, the BAD protein promotes cell death by 
binding to antiapoptotic proteins, such as Bcl-2 and Bcl-XL, 
which would otherwise inhibit BAX activity (Youle and 
Strasser, 2008). Phosphorylation of BAD triggers release of these 
prosurvival factors (Youle and Strasser, 2008). In pre–B cells, 
BAD is phosphorylated by Pim1 and Akt in response to IL-7 
(unpublished data). In the absence of IL-7, up-regulation 
of Pim2 by RAG DSBs maintains BAD phosphorylation 
(Fig. 3 K). Thus, although RAG DSBs induce BAX expres-
sion, they also promote Pim2-dependent phosphorylation of 
BAD, which will antagonize BAX proapoptotic activities.
Pim2 enforces the G1-S checkpoint in pre–B cells
The Pim kinases have established roles in promoting prolifer-
ation downstream of cytokine receptors (Amaravadi and 
Thompson, 2005; Nawijn et al., 2011). Consistent with this 
function, Pim1 is required to promote proliferation down-
stream of the IL-7 receptor (unpublished data and Domen 
et al., 1993). In stark contrast to the pro-proliferative activities 
of Pim1, we find that Pim2 enforces the G1 to S checkpoint, 
inhibiting the proliferation of pre–B cells with RAG DSBs. 
In this regard, Artemis/:Pim2/:IgH:Bcl2 pre–B cell cul-
tures have a higher percentage of S-phase cells than Artemis/:
IgH:Bcl2 pre–B cell cultures (Fig. 4 A). Indeed, the fraction 
of S-phase Artemis/:Pim2/:IgH:Bcl2 pre–B cells is similar 
to that of RAG1/:IgH:Bcl2 pre–B cells, which do not have 
RAG DSBs and do not activate DSB-dependent checkpoint 
pathways (Fig. 4 A). Expression of Pim2 in Artemis/:
Pim2/:IgH:Bcl2 pre–B cells leads to a decrease the percent-
age of S-phase cells (Fig. 4 B). However, expression of Pim2 
in RAG1/:IgH:Bcl2 pre–B cells does not alter the percent-
age of S-phase RAG1/:IgH:Bcl2 pre–B cells (Fig. 4 C). 
Together, these data demonstrate that RAG DSBs in pre–B 
cells activate the G1-S checkpoint in a manner dependent on 
Pim2 and that the antiproliferative properties of Pim2 are 
unique to cells with DNA breaks.
The contrasting effects of Pim1 and Pim2 on cell prolif-
eration are context dependent, permitting pre–B cell expan-
sion in the presence of IL-7 (Pim1) but preventing proliferation 
of pre–B cells that have initiated V(D)J recombination and 
have RAG DSBs (Pim2). In the latter context, Pim2 pro-
motes genomic stability by preventing cells with RAG DSBs 
from entering S phase where these breaks could be aberrantly 
repaired. Importantly, we show that the induction of Pim2 
by RAG DSBs inhibits pre–B cells from entering S phase 
even in the presence of IL-7. Thus, Pim2 would antagonize 
proliferative signals from any residual IL-7 present when pre–
B cells have transited away from IL-7–producing stromal cells 
(Tokoyoda et al., 2004; Johnson et al., 2008).
We have shown that distinct signaling pathways activated 
by the IL-7 receptor and by RAG DSBs are functionally inte-
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digested with SacI and EcoRI using the JIII probe as described previously 
(Bredemeyer et al., 2008).
Western blot and EMSA analyses. Western blots were done on whole cell 
lysates as previously described (Bredemeyer et al., 2008). Anti–phospho(Thr308)-
Akt, anti–total Akt, anti–phospho(Ser256)-Foxo1, anti–phospho(Ser15)-p53, 
and anti–phospho(Ser112)-BAD antibodies were obtained from Cell Signaling 
Technology. Anti-Pim1, anti-Pim2, and anti-Gapdh antibodies were obtained 
from Santa Cruz Biotechnology, Inc. Secondary reagents were horseradish per-
oxidase–conjugated goat anti–mouse IgG (Invitrogen) or donkey anti–rabbit IgG 
(GE Healthcare). Quantitation was done using ImageJ software (National Insti-
tutes of Health) and ratios of bands are all referenced to loading controls.
RT-PCR. RNA was isolated using RNeasy (QIAGEN) and reversed tran-
scribed using a polyT primer and SuperScriptII (Invitrogen) according to the 
manufacturers’ protocol. RT-PCR was performed using Brilliant II SYBR 
Green (Agilent Technologies) and acquired on an Mx3000P (Agilent Tech-
nologies). Each reaction was run in triplicate. Primer sequences were: Noxa 
(forward: 5-ACCACCTTAAATCCAGCTGTCCCA-3; reverse: 5-CCC-
TTCAGCCCTTGATTGCTTGTT-3), Puma (forward: 5-AGACAAGA-
AGAGCAGCATCGACAC-3; reverse: 5-TAGGCACCTAGTTGGGCT-
CCATTT-3), and Bax (forward: 5-TGTTTGCTGATGGCAACTTC-3; 
reverse: 5-GATCAGCTCGGGCACTTTAG-3).
Statistical analysis. All p-values were generated via Student’s t test using 
Prism (GraphPad Software).
Online supplemental material. Fig. S1 shows shows flow cytomet-
ric analysis of bone marrow from mice used to generate IL-7 cultures. 
Online supplemental material is available at http://www.jem.org/cgi/ 
content/full/jem.20112078/DC1.
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